Abstract
This chapter reviews the rationale for integrating smoking-cessation treatments into the standard medical care for head and neck cancer patients. The chapter identifies the potential determinants of smoking behavior in this population, including psychological, demographic, medical, and genetic factors. Despite the documented health advantage that smoking cessation can afford to cancer patients, many continue to smoke following diagnosis and treatment. Psychosocial and genetic factors may each play an important role in determining smoking cessation among head and neck cancer patients. In addition, emotional distress may be especially important to consider when designing a smoking-cessation intervention for head and neck cancer patients. These findings have important implications for the selection of appropriate smoking cessation interventions for head and neck cancer patients who continue to smoke. The chapter discusses the range of empirically based smoking cessation interventions and provides recommendations for smoking cessation treatment in this population, in addition to providing suggestions for future research.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
